The medicines decisions made at the NENC Clinical Effectiveness and Governance (CEG) Subcommittee August 2025 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/
This includes the recommendations made by NTAG at its July 2025 meeting and NICE Technology appraisals from the 1st April 2025 to 31st May 2025.
The following new guidelines were approved and can be found at:
- NENC Adult Asthma Guideline – https://ntag.nhs.uk/guidelines/
- NENC Vitamin D OTC Position Statement – https://ntag.nhs.uk/guidelines/
The following reviewed guidelines were approved and can be found at:
- NENC SGLT2-inhibitors and chronic kidney disease – patient information leaflet – https://ntag.nhs.uk/guidelines/
There has been a minor technical update to the following guidelines published on the 29th July 2025:
- NENC COPD Guideline – correction – update with lower carbon footprint for Bevespi, when it was Trixeo that had their product changed to lower carbon propellant in May 2025. On 15.7.25 we updated the carbon footprint for Bevespi but have been told this was an error.
The following were also approved:
- Proposal for standardisation of the specific IgE regional repertoire available for requesting in primary care
- NENC Spirometry Competency framework